{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:51:11Z","timestamp":1781092271375,"version":"3.54.1"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/bor.0000000000000214","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T15:00:26Z","timestamp":1440774026000},"page":"521-529","source":"Crossref","is-referenced-by-count":32,"title":["Genetics of systemic sclerosis"],"prefix":"10.1097","volume":"27","author":[{"given":"Paula S.","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Feghali-Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder.","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2007.12.001","article-title":"The many faces of scleroderma.","volume":"34","author":"Steen","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"R3-2-20210128","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients.","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","article-title":"Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.","volume":"81","author":"Scussel-Lonzetti","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R8-2-20210128","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.1780400421","article-title":"Racial differences in scleroderma among women in Michigan.","volume":"40","author":"Laing","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R9-2-20210128","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.114.3.801","article-title":"African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease.","volume":"114","author":"Greidinger","year":"1998","journal-title":"Chest"},{"key":"R11-2-20210128","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10654-005-2210-5","article-title":"Systemic sclerosis mortality in the United States: 1979-1998.","volume":"20","author":"Krishnan","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.22532","article-title":"Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors.","volume":"57","author":"McNearney","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R13-2-20210128","first-page":"263","article-title":"Racial variation in clinical and immunological manifestations of systemic sclerosis.","volume":"33","author":"Nietert","year":"2006","journal-title":"J Rheumatol"},{"key":"R14-2-20210128","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002.","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R15-2-20210128","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA.","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"key":"R16-2-20210128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaut.2008.05.002","article-title":"Polyautoimmunity and familial autoimmunity in systemic sclerosis.","volume":"31","author":"Hudson","year":"2008","journal-title":"J Autoimmun"},{"key":"R17-2-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1445-5994.1999.tb01586.x","article-title":"Familial risk estimation in systemic sclerosis.","volume":"29","author":"Englert","year":"1999","journal-title":"Aust N Z J Med"},{"key":"R18-2-20210128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2010.02.001","article-title":"Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.","volume":"35","author":"Arora-Singh","year":"2010","journal-title":"J Autoimmun"},{"key":"R19-2-20210128","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R20-2-20210128","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R21-2-20210128","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/art.27469","article-title":"Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study.","volume":"62","author":"Frech","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R22-2-20210128","doi-asserted-by":"crossref","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet"},{"key":"R23-2-20210128","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet"},{"key":"R24-2-20210128","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","article-title":"A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci.","volume":"22","author":"Martin","year":"2013","journal-title":"Hum Mol Genet"},{"key":"R25-2-20210128","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"key":"R26-2-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.","volume":"94","author":"Mayes","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R27-2-20210128","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13075-014-0438-8","article-title":"An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.","volume":"16","author":"Zochling","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R28-2-20210128","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/ddr522","article-title":"A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.","volume":"21","author":"Bossini-Castillo","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R29-2-20210128","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/dds099","article-title":"Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up.","volume":"21","author":"Martin","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R30-2-20210128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/annrheumdis-2012-201888","article-title":"Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.","volume":"72","author":"Bossini-Castillo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R31-2-20210128","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/art.38870","article-title":"Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus.","volume":"66","author":"Lopez-Isac","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R32-2-20210128","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/ar4432","article-title":"A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility.","volume":"16","author":"Lopez-Isac","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R33-2-20210128","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3899\/jrheum.090421","article-title":"Association of interleukin 23 receptor polymorphisms with antitopoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.","volume":"36","author":"Agarwal","year":"2009","journal-title":"J Rheumatol"},{"key":"R34-2-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2008.096719","article-title":"The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.","volume":"68","author":"Rueda","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R35-2-20210128","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/art.22196","article-title":"Association of the PTPN22 R620W polymorphism with antitopoisomerase I- and anticentromere antibody-positive systemic sclerosis.","volume":"54","author":"Gourh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R36-2-20210128","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.23601","article-title":"The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis.","volume":"58","author":"Dieude","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R37-2-20210128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.2010.130138","article-title":"Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.","volume":"70","author":"Diaz-Gallo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R38-2-20210128","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ard.2010.147009","article-title":"Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor.","volume":"70","author":"Dieude","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R39-2-20210128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.2009.116434","article-title":"Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.","volume":"69","author":"Gourh","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R40-2-20210128","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2010.141838","article-title":"A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.","volume":"70","author":"Bossini-Castillo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R41-2-20210128","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.111270","article-title":"Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis.","volume":"39","author":"Coustet","year":"2012","journal-title":"J Rheumatol"},{"key":"R42-2-20210128","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard.2009.111310","article-title":"Association of STAT4 polymorphism with systemic sclerosis in a Japanese population.","volume":"68","author":"Tsuchiya","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R43-2-20210128","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R44-2-20210128","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1Th2 cytokines.","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R45-2-20210128","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R46-2-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.33325","article-title":"A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.","volume":"64","author":"Broen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R47-2-20210128","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.24885","article-title":"BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R48-2-20210128","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2009.118174","article-title":"BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.","volume":"69","author":"Rueda","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R49-2-20210128","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/ard.2009.127928","article-title":"Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.","volume":"69","author":"Dieude","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R50-2-20210128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","article-title":"PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population.","volume":"65","author":"Terao","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R51-2-20210128","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/art.34490","article-title":"Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.","volume":"64","author":"Koumakis","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R52-2-20210128","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.38136","article-title":"A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis.","volume":"65","author":"Koumakis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R53-2-20210128","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R54-2-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R55-2-20210128","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3899\/jrheum.091163","article-title":"Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.","volume":"37","author":"Dieude","year":"2010","journal-title":"J Rheumatol"},{"key":"R56-2-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2009.08.014","article-title":"Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.","volume":"34","author":"Gourh","year":"2010","journal-title":"J Autoimmun"},{"key":"R57-2-20210128","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/art.27303","article-title":"Association of the FAM167A-BLK region with systemic sclerosis.","volume":"62","author":"Ito","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R58-2-20210128","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.30379","article-title":"C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis.","volume":"63","author":"Coustet","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R59-2-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/gene.2011.72","article-title":"The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.","volume":"13","author":"Martin","year":"2012","journal-title":"Genes Immun"},{"key":"R60-2-20210128","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/ard.2008.088989","article-title":"The -670GA polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.","volume":"68","author":"Liakouli","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R61-2-20210128","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/art.24964","article-title":"The FAS -670AG polymorphism influences susceptibility to systemic sclerosis phenotypes.","volume":"60","author":"Broen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R62-2-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","article-title":"Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.","volume":"71","author":"Carmona","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R63-2-20210128","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/art.27607","article-title":"Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population.","volume":"62","author":"Wipff","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R64-2-20210128","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/ard.2010.131243","article-title":"NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis.","volume":"70","author":"Dieude","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R65-2-20210128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.30204","article-title":"Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis.","volume":"63","author":"Dieude","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R66-2-20210128","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/art.22179","article-title":"Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma.","volume":"54","author":"Wu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R67-2-20210128","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/ker259","article-title":"Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.","volume":"50","author":"Bossini-Castillo","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R68-2-20210128","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/art.30640","article-title":"Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1196Phe532Ser haplotype.","volume":"63","author":"Dieude","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R69-2-20210128","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1136\/annrheumdis-2012-202742","article-title":"New insight on the Xq28 association with systemic sclerosis.","volume":"72","author":"Carmona","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R70-2-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","article-title":"Systemic sclerosis: genetics and epigenetics.","volume":"41","author":"Luo","year":"2013","journal-title":"J Autoimmun"},{"key":"R71-2-20210128","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00439-011-1137-z","article-title":"Unraveling the genetic component of systemic sclerosis.","volume":"131","author":"Martin","year":"2012","journal-title":"Hum Genet"},{"key":"R72-2-20210128","first-page":"9","article-title":"Genetics of scleroderma: implications for personalized medicine BMC M","volume":"11","author":"Assassi","year":"2013","journal-title":"ed"},{"key":"R73-2-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-kappaB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.","volume":"17","author":"Arismendi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R74-2-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-014-0484-x","article-title":"Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance.","volume":"17","author":"Korman","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R75-2-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874312901408010029","article-title":"Systemic sclerosis is a complex disease associated mainly with immune regulatory and inflammatory genes.","volume":"8","author":"Jin","year":"2014","journal-title":"Open Rheumatol J"},{"key":"R77-2-20210128","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.","volume":"10","author":"Broen","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R78-2-20210128","first-page":"1967","article-title":"Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct Arthritis R","volume":"66","author":"Herzog","year":"2014","journal-title":"heumatol"},{"key":"R79-2-20210128","doi-asserted-by":"crossref","first-page":"e1004005","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.","volume":"11","author":"Mahoney","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"R81-2-20210128","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/annrheumdis-2012-202357","article-title":"Implication of IL-2IL-21 region in systemic sclerosis genetic susceptibility.","volume":"72","author":"Diaz-Gallo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R82-2-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants.","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"R83-2-20210128","doi-asserted-by":"crossref","first-page":"976427","DOI":"10.1155\/2011\/976427","article-title":"Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.","volume":"2011","author":"Rigamonti","year":"2011","journal-title":"Int J Rheumatol"},{"key":"R84-2-20210128","first-page":"254319","article-title":"Introducing polyautoimmunity: secondary autoimmune diseases no longer exist.","volume":"2012","author":"Rojas-Villarraga","year":"2012","journal-title":"Autoimmune Dis"},{"key":"R85-2-20210128","doi-asserted-by":"crossref","first-page":"e1003447","DOI":"10.1371\/journal.pgen.1003447","article-title":"Analysis of the genetic basis of disease in the context of worldwide human relationships and migration.","volume":"9","author":"Corona","year":"2013","journal-title":"PLoS Genet"},{"key":"R87-2-20210128","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nri3421","article-title":"Population genetic tools for dissecting innate immunity in humans.","volume":"13","author":"Quintana-Murci","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R88-2-20210128","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1172\/JCI74368","article-title":"Fibrosis: ultimate and proximate causes.","volume":"124","author":"Thannickal","year":"2014","journal-title":"J Clin Invest"},{"key":"R89-2-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14248","article-title":"Integrative analysis of 111 reference human epigenomes.","volume":"518","author":"Roadmap Epigenomics","year":"2015","journal-title":"Nature"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:09:08Z","timestamp":1718050148000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201511000-00002"}},"subtitle":["recent advances"],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000214","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}